21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10 - Manufacture of food products
20 - Manufacture of chemicals and chemical products
21.10.Z - Manufacture of basic pharmaceutical products
32 - Other manufacturing of products
46 - Wholesale trade
47 - Retail trade
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
75 - Veterinary activities
77 - Rental and leasing
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,5 | 6,3 | 5,5 | -12,1 |
EBITDA | 7,9 | 12,7 | 12,8 | 0,9 |
Short time liabilities | 16,7 | 23,6 | 16,8 | -29,1 |
Equity capital | 53,6 | 59,9 | 65,4 | 9,2 |
Operating profit (EBIT) | 3,1 | 7,5 | 7,3 | -2,9 |
Assets | 92,4 | 104,9 | 121,1 | 15,4 |
Net profit (loss) | 1,5 | 6,3 | 5,5 | -12,1 |
Cash | 0,1 | 0,1 | 4,2 | 2779 |
Net income from sale | 33,9 | 48,3 | 40 | -17,3 |
Liabilities and provisions for liabilities | 38,8 | 45 | 55,7 | 23,8 |
Working assets | 18,7 | 14,9 | 25,8 | 73,4 |
Depreciation | 4,8 | 5,3 | 5,6 | 6,3 |
% | % | % | p.p. | |
Profitability of capital | 2,8 | 10,5 | 8,4 | -2,1 |
Equity capital to total assets | 58 | 57,1 | 54 | -3,1 |
Gross profit margin | 4,5 | 13 | 13,8 | 0,8 |
EBITDA Margin | 23,3 | 26,4 | 32,2 | 5,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 180 | 179 | 153 | -26 |
Current financial liquidity indicator | 0.7783305644989014 | 0.48397862911224365 | 1.082797646522522 | 0,6 |
Net dept to EBITDA | 2.576253652572632 | 1.795560598373413 | 2.9004201889038086 | 1,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane